Bausch Health Companies Inc (BHC)
8.09
-0.09
(-1.10%)
USD |
NYSE |
Nov 22, 15:06
Bausch Health Total Assets (Quarterly): 26.54B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 26.54B |
| June 30, 2024 | 26.50B |
| March 31, 2024 | 26.91B |
| December 31, 2023 | 27.35B |
| September 30, 2023 | 27.06B |
| June 30, 2023 | 25.50B |
| March 31, 2023 | 25.44B |
| December 31, 2022 | 25.69B |
| September 30, 2022 | 26.30B |
| June 30, 2022 | 28.17B |
| March 31, 2022 | 29.09B |
| December 31, 2021 | 29.20B |
| September 30, 2021 | 29.25B |
| June 30, 2021 | 30.04B |
| March 31, 2021 | 30.20B |
| December 31, 2020 | 31.20B |
| September 30, 2020 | 31.56B |
| June 30, 2020 | 31.40B |
| March 31, 2020 | 31.86B |
| December 31, 2019 | 33.86B |
| September 30, 2019 | 31.67B |
| June 30, 2019 | 32.35B |
| March 31, 2019 | 32.55B |
| December 31, 2018 | 32.49B |
| September 30, 2018 | 33.78B |
| Date | Value |
|---|---|
| June 30, 2018 | 34.45B |
| March 31, 2018 | 35.80B |
| December 31, 2017 | 37.50B |
| September 30, 2017 | 39.97B |
| June 30, 2017 | 41.73B |
| March 31, 2017 | 42.33B |
| December 31, 2016 | 43.53B |
| September 30, 2016 | 45.76B |
| June 30, 2016 | 47.66B |
| March 31, 2016 | 49.02B |
| December 31, 2015 | 48.96B |
| September 30, 2015 | 48.45B |
| June 30, 2015 | 48.34B |
| March 31, 2015 | 38.57B |
| December 31, 2014 | 26.30B |
| September 30, 2014 | 27.06B |
| June 30, 2014 | 27.90B |
| March 31, 2014 | 27.99B |
| December 31, 2013 | 27.97B |
| September 30, 2013 | 28.20B |
| June 30, 2013 | 19.78B |
| March 31, 2013 | 17.49B |
| December 31, 2012 | 17.95B |
| September 30, 2012 | 14.15B |
| June 30, 2012 | 14.02B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.44B
Minimum
Mar 2023
33.86B
Maximum
Dec 2019
28.66B
Average
28.63B
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 132.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.78B |
| Shareholders Equity (Quarterly) | -1.174B |
| Debt to Equity Ratio | -18.32 |
| Current Ratio | 1.188 |
| Net Debt Paydown Yield | -6.37% |